Back
Is Dose Adjustment Based on Several Factors of Body Size Descriptors Effective for Prevention of Thrombocytopenia by Linezolid Therapy in Hemodialysis Patients?
Hideo Kato, Mao Hagihara, Yuka Yamagishi, Yukihiro Hamada, Jun Hirai, Naoya Nishiyama, Yusuke Koizumi, Katsuhiko Matsuura, Hiroshige Mikamo
Pharmacol. Pharm. Vol.7 No.10, October 27, 2016  DOI: 10.4236/pp.2016.710049
       (PDF  452K)     HTML      XML
Staphylococcus haemolyticus superinfection of legionella pneumonia during infliximab therapy
Marianna Porzio, Luca Valenti, Daniela Bignamini, Francesca Ricchini, Alessandro Palleschi, Paolo Tarsia, Silvia Fargion
Open J. Intern. Med. Vol.1 No.1, June 29, 2011  DOI: 10.4236/ojim.2011.11003
       (PDF  147K)     HTML     
Staphylococcus haemolyticus superinfection of legionella pneumonia during infliximab therapy
Marianna Porzio, Luca Valenti, Daniela Bignamini, Francesca Ricchini, Alessandro Palleschi, Paolo Tarsia, Silvia Fargion
Open J. Intern. Med. Vol.1 No.1, June 29, 2011  DOI: 10.4236/ojim.2011.11003
       (PDF  147K)     HTML     
The Prevalence of Methicillin-Resistant Staphylococcus aureus Colonization in Patients with Complicated Skin and Skin Structure Infections after Treatment with Linezolid or Vancomycin
Laura A. Puzniak, Kimbal D. Ford, David B. Huang
Adv. Infect. Dis. Vol.4 No.4, November 28, 2014  DOI: 10.4236/aid.2014.44026
       (PDF  2728K)     HTML      XML
Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus in Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia at Tertiary Care Hospital
Eman Mohammad Hamdan, Majda Al-Attas
Adv. Infect. Dis. Vol.7 No.1, March 01, 2017  DOI: 10.4236/aid.2017.71002
       (PDF  768K)     HTML      XML
 
 
Top